Combined sialic acid and histone deacetylase (HDAC) inhibitor treatment up-regulates the neuroblastoma antigen GD2

van den Bijgaart, R.J.E., Kroesen, M., Wassink, M., Brok, I.C., Kers-Rebel, E.D., L. Boon (Louis), Heise, T., M. van Scherpenzeel (Monique), D.J. Lefeber (Dirk), Boltje, T.J., et al. G.J. Adema (Gosse)

2019-03-01

Journal of Biological Chemistry , Volume 294 - Issue 12 p. 4437- 4449

Additional Metadata
Persistent URL	doi.org/10.1074/jbc.RA118.002763, hdl.handle.net/1765/116290
Journal	Journal of Biological Chemistry
Organisation	Radiotherapy
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van den Bijgaart, R.J.E., Kroesen, M., Wassink, M., Brok, I.C., Kers-Rebel, E.D., Boon, L., … Adema, G. (2019). Combined sialic acid and histone deacetylase (HDAC) inhibitor treatment up-regulates the neuroblastoma antigen GD2. Journal of Biological Chemistry, 294(12), 4437–4449. doi:10.1074/jbc.RA118.002763

Publication